Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06201416
PHASE1

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

Sponsor: Sonoma Biotherapeutics, Inc.

View on ClinicalTrials.gov

Summary

This study will test the safety and effects of SBT777101 when given as a single dose to subjects with rheumatoid arthritis. It is the first study of this treatment being done in humans. Increasing dose levels will be given after the safety at lower dose levels is shown.

Official title: A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Activity of Single Ascending Doses of SBT777101 in Subjects With Rheumatoid Arthritis

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2024-03-06

Completion Date

2026-03

Last Updated

2024-11-27

Healthy Volunteers

No

Interventions

BIOLOGICAL

SBT777101

Experimental treatment

Locations (8)

Mayo Clinic

Scottsdale, Arizona, United States

UCSF Medical Center

San Francisco, California, United States

Stanford Medical Center

Stanford, California, United States

University of Colorado

Aurora, Colorado, United States

Northwestern University

Chicago, Illinois, United States

Tufts University

Boston, Massachusetts, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

Brigham and Women's Hospital

Boston, Massachusetts, United States